NLRP1 and preeclampsia: There is a higher endogenous activation of NLRP1/NLRP3 inflammasomes in the monocytes from preeclamptic women than normotensive pregnant women, but Silibinin can inhibit NLRP1/NLRP3 inflammasomes in monocytes from pregnant women with preeclampsia [53].